TCL Archive Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2 April 17, 1987
TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975
TCL Archive Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says July 18, 1986